| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Resverlogix Corp (TO: RVX)
RVX Technical Analysis
5
| As on 21st Nov 2025 RVX STOCK Price closed @ 0.12 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.06 & Strong Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RVXSTOCK Price
| Open | 0.11 | Change | Price | % |
| High | 0.12 | 1 Day | 0.02 | 20.00 |
| Low | 0.11 | 1 Week | 0.02 | 20.00 |
| Close | 0.12 | 1 Month | 0.02 | 20.00 |
| Volume | 84000 | 1 Year | 0.06 | 100.00 |
| 52 Week High 0.22 | 52 Week Low 0.04 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| CNQ | 47.11 | -1.65% |
| FF | 0.33 | 3.12% |
| UEX | 0.50 | 16.28% |
| T | 18.71 | -0.69% |
| CVE | 25.20 | -1.10% |
| SLF | 84.00 | 1.49% |
| MFC | 48.66 | 1.80% |
| BTE | 4.46 | -0.45% |
| SJR-B | 40.48 | 0.02% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| RVX Daily Charts |
RVX Intraday Charts |
Whats New @ Bazaartrend |
RVX Free Analysis |
|
|
RVX Important Levels Intraday
| RESISTANCE | 0.14 |
| RESISTANCE | 0.13 |
| RESISTANCE | 0.13 |
| RESISTANCE | 0.13 |
| SUPPORT | 0.11 |
| SUPPORT | 0.11 |
| SUPPORT | 0.11 |
| SUPPORT | 0.10 |
RVX Forecast November 2025
| 4th UP Forecast | 0.16 |
| 3rd UP Forecast | 0.15 |
| 2nd UP Forecast | 0.14 |
| 1st UP Forecast | 0.13 |
| 1st DOWN Forecast | 0.11 |
| 2nd DOWN Forecast | 0.1 |
| 3rd DOWN Forecast | 0.09 |
| 4th DOWN Forecast | 0.08 |
RVX Weekly Forecast
| 4th UP Forecast | 0.12 |
| 3rd UP Forecast | 0.12 |
| 2nd UP Forecast | 0.12 |
| 1st UP Forecast | 0.12 |
| 1st DOWN Forecast | 0.12 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | 0.12 |
| 4th DOWN Forecast | 0.12 |
RVX Forecast2025
| 4th UP Forecast | 0.62 |
| 3rd UP Forecast | 0.46 |
| 2nd UP Forecast | 0.36 |
| 1st UP Forecast | 0.26 |
| 1st DOWN Forecast | -0.02 |
| 2nd DOWN Forecast | -0.12 |
| 3rd DOWN Forecast | -0.22 |
| 4th DOWN Forecast | -0.38 |
Resverlogix Corp ( TO Canada Symbol : RVX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RVX Other Details
| Segment | EQ | |
| Market Capital | 116039512.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
RVX Address
![]() |
||
RVX Latest News
RVX Business Profile
Resverlogix Corp. operates as a late-stage clinical biotechnology company. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular, end-stage renal, chronic kidney, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the initial commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada. Address: 4820 Richard Road SW, Calgary, AB, Canada, T3E 6L1
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

